Millipore Report issue

For profit Phase 3
Founded: Billerica MA United States (1954)
Status: Acquired by Merck KGaA (2010) → now Merck Serono (2006)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Millipore (0) Acquired (1)

cmv-specific t-cells (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1